XML 100 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation (Tables)
3 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract]    
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]  
A summary of stock-based compensation costs is as follows (in millions):
 Year Ended December 31,
 202320222021
 
Notional stock units and stock appreciation rights$1.0 $0.9 $11.6 
Restricted stock0.4 0.2 — 
BOD and employee restricted stock units0.9 0.7 0.5 
Stock options— 0.1 0.1 
Total stock-based compensation costs$2.3 $1.9 $12.2 
Total recognized tax benefit$(0.3)$(0.2)$(1.5)
Share-based Payment Arrangement, Nonemployee Director Award Plan, Activity [Table Text Block]  
The following table summarizes Centrus’ board restricted stock units activity:
Shares (in thousands)Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2020
47$10.38
Granted20$25.13
Vested(47)$10.38
Forfeited
Nonvested at December 31, 2021
20$25.13
Granted28$38.80
Vested(20)$25.13
Forfeited
Nonvested at December 31, 2022
28$38.80
Granted17$35.95
Vested(28)$38.80
Forfeited
Nonvested at December 31, 2023
17$35.95
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]  
The following table summarizes Centrus’ employee restricted stock units activity:
Shares
(in thousands)
Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2020
Granted4$24.01
Vested
Forfeited
Nonvested at December 31, 2021
4$24.01
Granted
Vested(1)$24.01
Forfeited
Nonvested at December 31, 2022
3$24.01
Granted20$55.54
Vested (1)$24.01
Forfeited(1)$24.01
Nonvested at December 31, 2023
21$54.04
Share-based Compensation, Stock Options, Activity [Table Text Block]   A summary of stock option activity follows:
Stock Options (in thousands)Weighted Average Exercise PriceWeighted Average Remaining Contractual Life in YearsAggregate Intrinsic Value (in millions)
Outstanding at December 31, 2020
411$4.185.3$7.8
Granted
Exercised(217)$4.17
Forfeited/Cancelled
Outstanding at December 31, 2021
194$4.184.4$8.9
Granted
Exercised(98)$4.00
Forfeited/Cancelled
Outstanding at December 31, 2022
96$4.372.2$2.7
Granted
Exercised
Forfeited/Cancelled
Outstanding at December 31, 2023
96$4.370.3$4.8
Exercisable at December 31, 2023
96$4.370.3$4.8
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]  
Stock options outstanding and options exercisable at December 31, 2023, are as follows:
Stock Exercise PriceOptions Outstanding (thousands)Remaining Contractual Life in YearsOptions Exercisable (thousands)
$4.37960.396
Share-based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]  
A summary of SARs with time-based vesting granted under the 2014 Plan for the year ended December 31, 2023, are as follows:
Stock Appreciation Rights (in thousands) Weighted Average Exercise PriceWeighted Average Remaining Contractual Life in YearsAggregate Intrinsic Value (in millions)
Outstanding at December 31, 2020
84$5.532.3$1.5
Granted
Exercised
Forfeited/Cancelled
Outstanding at December 31, 2021
84$5.531.3$3.7
Granted
Exercised
Forfeited/Cancelled(14)$5.53
Outstanding at December 31, 2022
70$5.530.3$2.7
Granted
Exercised(74)$5.53
Forfeited/Cancelled4$5.53
Outstanding at December 31, 2023
Exercisable at December 31, 2023
Share-based Payment Arrangement, Stock Appreciation Right, Performance Condition, Activity [Table Text Block]
A summary of SARs with performance-based vesting granted under the 2014 Plan in the year ended December 31, 2023, are as follows:

Stock Appreciation Rights (Performance Condition) (in thousands)Weighted Average Exercise PriceWeighted Average Remaining Contractual Life in YearsAggregate Intrinsic Value (in millions)
Outstanding at December 31, 2020
Granted21$19.44
Exercised
Forfeited/Cancelled
Outstanding at December 31, 2021
21$19.442.3$0.6
Granted
Exercised
Forfeited/Cancelled(3)$19.44
Outstanding at December 31, 2022
18$19.441.3
Granted
Exercised
Forfeited/Cancelled(1)$19.44
Outstanding at December 31, 2023
17$19.440.2$0.3
Exercisable at December 31, 2023
17$19.440.2$0.3
 
Schedule of Share-based Payment Award, Stock Appreciation Rights, Performance Condition, Valuation Assumptions [Table Text Block]  
The weighted-average assumptions used in the valuation models to determine the fair value of SARs granted to employees under the 2014 Plan are as follows:

Year Ended December 31,
202320222021
Stock Appreciation Rights Granted (in thousands)n/an/a21.0
Average Risk-Free Raten/an/a0.3%
Expected Volatilityn/an/a82.8%
Expected Term (Years)n/an/a2.5
Dividend Yieldn/an/a
Schedule of Notional Stock Units, Activity [Table Text Block]  
A summary of notional stock units with time-based vesting granted under the 2014 Plan for the year ended December 31, 2023, are as follows:

Shares (thousands)Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2020
571$3.68
Granted
Vested
(319)
Forfeited/Cancelled
Nonvested at December 31, 2021
252$4.33
Granted
Vested(128)$3.16
Forfeited(2)$5.53
Nonvested at December 31, 2022
122$5.53
Granted
Vested(104)$5.53
Forfeited(18)$5.53
Nonvested at December 31, 2023
Schedule of Notional Stock Units, Performance Condition, Activity [Table Text Block]  
A summary of notional stock units with performance-based vesting granted under the 2014 Plan for the year ended December 31, 2023, are as follows:

Shares
(in thousands)
Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2020
Granted10$39.55
Vested
Forfeited
Nonvested at December 31, 2021
10$39.55
Granted
Vested
Forfeited(2)$39.55
Nonvested at December 31, 2022
8$39.55
Granted
Vested
Forfeited
Nonvested at December 31, 2023
8$39.55
Restricted Stock (Performance Condition) - 2022 Award

A summary of restricted stock with performance-based vesting granted under the 2014 Plan for the year ended December 31, 2023, are as follows:

Shares
(in thousands)
Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2021
Granted24$33.70
Vested
Forfeited(2)$33.70
Nonvested at December 31, 2022
22$33.70
Granted
Vested
Forfeited(5)$33.70
Nonvested at December 31, 2023
17$33.70
A summary of restricted stock with performance-based vesting granted under the 2014 Plan for the year ended December 31, 2023, are as follows:

Shares
(in thousands)
Weighted Average Grant Date Fair Value (per share)
Nonvested at December 31, 2022
Granted17$42.70
Vested
Forfeited(6)$42.70
Nonvested at December 31, 2023
11$42.70